Metabolic profiling--IBC's inaugural meeting. Using metabolomics to accelerate drug discovery and development. 14-15 November 2005, Durham, NC, USA
Harrigan, G.G.
IDrugs the investigational drugs journal 9(1): 28-31
2006
ISSN/ISBN: 1369-7056 PMID: 16374729 Document Number: 600519
Document emailed within 1 workday
Related Documents
Young, S.S. 1999: Discovery 99: accelerate and improve the drug discovery process. 26-29 April 1999, San Diego, CA, USA IDrugs: the investigational drugs journal 2(7): 648-649Mastrangelo, A.; Armitage, E.G.; García, A.; Barbas, C. 2014: Metabolomics as a tool for drug discovery and personalised medicine. A review Current Topics in Medicinal Chemistry 14(23): 2627-2636
Ashizawa, K. 2006: Physicochemical profiling and preformulation studies at the drug discovery stage Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 127(3): 213-216
Oshika, T.; Amano, S.; Nishida, K.; Saika, S.; Fukushima, A. 2014: "Another stimulating meeting on basic and clinical corneal research," 19th Annual Meeting of the Kyoto Cornea Club, November 29-30, 2013 Cornea 33 Suppl. 11: S1-S2
Burton, C.; Ma, Y. 2019: Current Trends in Cancer Biomarker Discovery Using Urinary Metabolomics: Achievements and New Challenges Current Medicinal Chemistry 26(1): 5-28
Cárdenas, M.L.; Cornish-Bowden, A. 2000: Metabolic analysis in drug discovery Science 288(5466): 618-619
Castro-Santos, P.; Laborde, C.M.; Díaz-Peña, R. 2015: Genomics, proteomics and metabolomics: their emerging roles in the discovery and validation of rheumatoid arthritis biomarkers Clinical and Experimental Rheumatology 33(2): 279-286
Perret, C. 1993: Introductory address to the inaugural lecture of Professor Ferdy Lejeune on 12 November 1992 Revue Medicale de la Suisse Romande 113(1): 9-10
Alhenc-Gelas, Fçois.; Parmentier, L.; Bisagni, A. 2003: Pharmacogenetic and pharmacogenomic studies. Impact on drug discovery and drug development Therapie 58(3): 275-282
Dunn, P.J. 1975: Rosenhahnite, a second occurrence with the zeolites of the Durham Quarry; Durham, Wake County, North Carolina The Mineralogical Record 6(6): 300-301
Kojima, H.; Okabe, T.; Nagano, T. 2013: Open innovation center for drug discovery: a research-supporting network for drug discovery Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 141(6): 327-332
Fujita, Y. 2013: Innovation by TaNeDS (Take a New challenge of Drug diScovery) collaborative drug discovery project Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(2): 89-95
McGowan, J.; Hoth, D. 1989: AIDS drug discovery and development Journal of Acquired Immune Deficiency Syndromes 2(4): 335-343
Lucignani, G.; Bastianello, S. 2007: Pharmacological MRI: a biomarker in CNS drug discovery and development? Functional Neurology 22(2): 71-73
Schacter, L.P.; Anderson, C.; Canetta, R.M.; Kelley, S.; Nicaise, C.; Onetto, N.; Rozencweig, M.; Smaldone, L.; Winograd, B. 1992: Drug discovery and development in the pharmaceutical industry Seminars in Oncology 19(6): 613-621
Lowe, J.A.; Jones, P.; Wilson, D.M. 2009: The importance of target validation in drug discovery and development Current Opinion in Drug Discovery and Development 12(5): 581-584
Amanfu, R.K.; Saucerman, J.J. 2011: Cardiac models in drug discovery and development: a review Critical Reviews in Biomedical Engineering 39(5): 379-395
Yamada, H. 2013: Application of translational research to drug discovery and development Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 141(3): 121
2006: NIAID researchers make key discovery in development of TB drug candidate Journal of investigative medicine: the official publication of the American Federation for Clinical Research 54(2): 53-54
Nassar, A-Eldin.F.; Lopez-Anaya, A. 2004: Strategies for dealing with reactive intermediates in drug discovery and development Current Opinion in Drug Discovery and Development 7(1): 126-136